As some 30,000 doctors, patient advocates, healthcare companies and journalists descended on Chicago for ASCO, there was a great deal of anticipation about what new research would be presented, and what kind of conversation and controversy might arise as a result.

That anticipation, it turns out, requires some patience, filtering, and a really big net.  In fact, the amount of clinical data available in oncology has increased exponentially over the last several years –the number of cancer-related journal articles posted to PubMed has increased 349% since 1999.  It should be no surprise that the number of cancer-related conversations has exploded in similar fashion.

Read Full Article